62
Participants
Start Date
May 1, 2024
Primary Completion Date
April 8, 2025
Study Completion Date
June 1, 2026
Pomalidomide
Oral pomalidomide up to 4 mg daily
University of Pennsylvania, Philadelphia
Johns Hopkins University, Baltimore
University of North Carolina, Chapel HIll, Chapel Hill
University of Florida, Gainesville
Cleveland Clinic, Cleveland
Medical College of Wisconsin, Milwaukee
Mayo Clinic, Rochester
University of Utah, Salt Lake City
University of California-San Diego, San Diego
University of California-San Francisco, San Francisco
Massachusetts General Hospital, Boston
Collaborators (1)
The Cleveland Clinic
OTHER
University of North Carolina, Chapel Hill
OTHER
University of California, San Francisco
OTHER
Mayo Clinic
OTHER
University of Utah
OTHER
University of California, San Diego
OTHER
University of Florida
OTHER
Medical College of Wisconsin
OTHER
Johns Hopkins University
OTHER
University of Pennsylvania
OTHER
Massachusetts General Hospital
OTHER